The Berlin Institute of Health (BIH) is a biomedical research institution focusing on translational research and precision medicine. The BIH is dedicated to improving the prediction in progressive diseases and developing advanced therapies for unmet medical needs in order to improve patients’ health and quality of life. The Institute is committed to providing research solutions and innovation enabling value-based, personalized healthcare. The BIH is funded 90% by the Federal Ministry of Education and Research (BMBF) and 10% by the State of Berlin. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), are independent, member entities within the BIH.

Life Sciences

Health Care

Research

Berlin Institute of Health

Katharina Erb-Eigner

Carla Frau 🧫

Stefan Habringer

Ludovic Vallier

Inés Simó

David Higgins

Alexandra Friedrich

Vince Madai

The Research and Science team at the Berlin Institute of Health focuses on conducting cutting-edge biomedical research to advance translational medicine and precision healthcare. They develop innovative therapies and predictive models for progressive diseases, working collaboratively across disciplines to bridge the gap between laboratory discoveries and clinical applications. The team comprises a diverse array of experts including scientists, clinicians, and researchers, all dedicated to improving patient outcomes and quality of life through scientific excellence and innovative healthcare solutions.

Research and Science

Research and Science

About

Team members